Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K

被引:50
作者
Becker, Renate [1 ,2 ]
Lenter, Martin C. [3 ]
Vollkommer, Tobias [1 ,2 ]
Boos, Anja M. [1 ,2 ]
Pfaff, Dennis [1 ,2 ]
Augustin, Hellmut G. [1 ,2 ]
Christian, Sven [1 ,2 ]
机构
[1] German Canc Res Ctr, INF 581, D-69221 Heidelberg, Germany
[2] Univ Heidelberg, Fac Med, Joint Res Div Vasc Biol, D-69221 Heidelberg, Germany
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Genom Grp Prote, Biberach, Germany
关键词
activated fibroblasts; mural cells;
D O I
10.1096/fj.07-101386
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor development involves complex bidirectional interactions between tumor cells and host stromal cells. Endosialin (Tem1) has been identified as a highly O-glycosylated transmembrane glycoprotein, which is specifically expressed by tumor vessel-associated pericytes and stromal fibroblasts of a wide range of human tumors. Recent experiments in endosialin-deficient mice have unraveled a critical role of endosialin in site-specific tumor progression and metastasis. To molecularly understand the mechanisms of endosialin function, we aimed to identify extracellular endosialin ligands and identified Mac-2 BP/90K as a specific interaction partner. Detailed biochemical analyses identified a C-terminal fragment of Mac-2 BP/90K, which was shown to contain binding sites for galectin- 3, and collagens as the structures responsible for endosialin binding. Subsequent expression analysis of Mac-2 BP/90K in vivo revealed weak or no expression in most normal tissues and strong up-regulation in tumor cells of human neoplastic tissues. Intriguingly, the expression patterns of Mac-2 BP/90K and endosialin were mutually exclusive in all human tissues. Correspondingly, loss-of-function adhesion experiments of Mac-2 BP/90K-expressing tumor cells on endosialin-expressing fibroblasts revealed a repulsive outcome of the Mac-2 BP/90K interaction. Taken together, the experiments identify a novel repulsive interaction between endosialin on stromal fibroblasts and Mac-2 BP/90K on tumor cells.
引用
收藏
页码:3059 / 3067
页数:9
相关论文
共 28 条
[1]   SELECTINS [J].
BEVILACQUA, MP ;
NELSON, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) :379-387
[2]   Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium [J].
Christian, S ;
Ahorn, H ;
Novatchkova, M ;
Garin-Chesa, P ;
Park, JE ;
Weber, G ;
Eisenhaber, F ;
Rettig, WJ ;
Lenter, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :48588-48595
[3]   Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium [J].
Christian, S ;
Ahorn, H ;
Koehler, A ;
Eisenhaber, F ;
Rodi, HP ;
Garin-Chesa, P ;
Park, JE ;
Rettig, WJ ;
Lenter, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7408-7414
[4]   Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells [J].
Christian, Sven ;
Winkler, Renate ;
Helfrich, Iris ;
Boos, Anja M. ;
Besemfelder, Eva ;
Schadendorf, Dirk ;
Augustin, Hellmut G. .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (02) :486-494
[5]   Angiogenesis as a therapeutic target [J].
Ferrara, N ;
Kerbel, RS .
NATURE, 2005, 438 (7070) :967-974
[6]   Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats [J].
Fiedler, U ;
Krissl, T ;
Koidl, S ;
Weiss, C ;
Koblizek, T ;
Deutsch, U ;
Martiny-Baron, G ;
Marmé, D ;
Augustin, HG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1721-1727
[7]   CLONING AND CHARACTERIZATION OF CYCLOPHILIN C-ASSOCIATED PROTEIN - A CANDIDATE NATURAL CELLULAR LIGAND FOR CYCLOPHILIN-C [J].
FRIEDMAN, J ;
TRAHEY, M ;
WEISSMAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6815-6819
[8]   Repulsion or adhesion: receptors make the call [J].
Halloran, Mary C. ;
Wolman, Marc A. .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (05) :533-540
[9]   Functional studies on recombinant domains of Mac-2-binding protein [J].
Hellstern, S ;
Sasaki, T ;
Fauser, C ;
Lustig, A ;
Timpl, R ;
Engel, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :15690-15696
[10]   PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER [J].
IACOBELLI, S ;
SISMONDI, P ;
GIAI, M ;
DEGIDIO, M ;
TINARI, N ;
AMATETTI, C ;
DISTEFANO, P ;
NATOLI, C .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :172-176